SCHEDULE: FMR LLC Discloses 10.1% Stake in Veracyte Inc
Schedule 13G
FMR LLC and Abigail P. Johnson have reported a 10.1% beneficial ownership stake in Veracyte Inc as of May 29, 2026.
Summary
- FMR LLC filed a Schedule 13G indicating beneficial ownership of 8,059,903.11 shares of Veracyte Inc common stock.
- The reported stake represents 10.1% of the company's outstanding common stock.
- The filing confirms that these shares are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral regulatory event, as it is a standard disclosure of existing institutional ownership rather than a change in company fundamentals.
Positives
- Institutional backing from a major investment firm like FMR LLC often signals confidence in the company's long-term prospects.
Negatives
- None identified; this is a standard regulatory disclosure of beneficial ownership.
Risks
- None identified; the filing explicitly states the shares are held for investment purposes only.
Future Outlook
The filing does not provide forward-looking guidance regarding the company's operations or the investor's future trading intentions.
Industry Context
StockSavvy.ai notes that Schedule 13G filings are routine disclosures for institutional investors. The presence of FMR LLC as a 10% shareholder is consistent with their role as a major institutional asset manager across the healthcare and biotechnology sectors.
Comparison to Industry Standards
- The disclosure follows standard SEC requirements for institutional investors exceeding the 5% ownership threshold.
- The reporting structure is consistent with typical filings from large asset managers like Fidelity.
Stakeholder Impact
- Shareholders may view the continued 10.1% stake by a major institutional investor as a sign of stability.
Next Steps
- No specific future actions or milestones were disclosed in this filing.
Key Dates
| Date | Description |
|---|---|
| 2023-01-03 | Effective date of Power of Attorney for FMR LLC. |
| 2023-01-26 | Effective date of Power of Attorney for Abigail P. Johnson. |
| 2026-05-29 | Date of event requiring the filing of this statement. |
| 2026-06-04 | Date of the filing. |
Keywords
Veracyte, FMR LLC, Schedule 13G, Institutional Ownership, Abigail Johnson, SEC Filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.